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LETTERS TO THE EDITOR 
Interleukin-lO concentration in children 
undergoing cardiopulmonary bypass 
To the Editor: 
We read with interest the article by Seghaye and 
associates, 3 "Interleukin-10 Release Related to Cardio- 
pulmonary Bypass in Infants Undergoing Cardiac Opera- 
tions." 
We also evaluated the interleukin-10 (IL-10) concentra- 
tion in 13 children (age range 1.2 to 12.7 years, average 5.1 
years) undergoing cardiac operations for congenital heart 
disease. Arterial blood samples were obtained before, im- 
mediately after, and 30 minutes after protamine administra- 
tion and then 3 hours after and 18 hours after cardiopulmo- 
nary bypass (CPB). Serum was separated immediately by 
centrifugation and specimens were stored at -20°C until 
use. The serum concentration of IL-8 was measured by 
means of a commercially available enzyme-linked immu- 
nosorbent assay (Sumitomokinzoku Bioassay Laboratories, 
Kanagawa, Japan). In our study, IL-10 concentrations before 
CPB (247.4 + 205.1 pg/ml) increased immediately after CPB 
(349.5 -+ 252.7 pg/ml, p < 0.01), peaked 30 minutes after 
protamine administration (628.5 + 258.0 pg/ml), then grad- 
ually decreased, and there was no second release of IL-10 
(Fig. 1). The course of IL-10 in our study was similar to that 
of IL-8 in our study and in their study. 
In our study, however, there were some differences 
from their study. First, patients in our study were older 
than those in their study, whereas duration of CPB and 
aortic crossclamping (86.6 -+ 40.2 minutes and 49.2 _+ 27.8 
minutes, respectively) were similar to those of their study. 
Second, IL-10 concentrations before CPB in eight of 13 
children were already higher than 200 pg/ml with no 
explanationl Third, in all patients,/3-methasone (3 mg/kg) 
was used for priming. 
We cannot explain why the course of IL-f0 in our study 
was so different from the course in their study, and we 
would like to investigate further. 
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Fig. 1. Course of IL-10 before and after CPB in !3 
children. Values are expressed by mean _+ standard 
deviation. *Significant difference in IL-10 concentration 
compared with baseline values (p < 0.05). A, Before CPB; 
B, immediately after CPB; C, 30 minutes after protamine 
administration; D, 3 hours after CPB; E, 18 hours after 
CPB. 
Reply to the Editor: 
The report by Sugita and associates, in comparison with 
our observation, shows some differences with respect o 
the mean prebypass values of interleukin-10 (IL-10) and 
the course of this natural antiinftammatory cytokine dur- 
ing and after cardiopulmonary b pass (CPB). 
Although the sensitivity of the assay that was used in the 
study by Sugita and associates for IL-10 determinations is 
not specified, it seems obvious that some of the patients 
had abnormally elevated IL-10 levels before CPB. In 
accordance with other reports in adults ~'2 we find low 
prebypass IL-10 concentrations in our patients. The ele- 
vated prebypass IL-10 concentrations measured by Sugi- 
ta's group raise the question of whether preoperative 
infectious or inflammatory disease was present in some of 
the patients of the series investigated. Furthermore, as 
tumor necrosis factor-c~ is thought o be the main inductor 
for IL-10 production, 3 it would be interesting to know the 
preoperative levels of tumor necrosis factor-a in the 
patients with abnormally high IL-10 concentrations as 
well. The preoperative administration of drugs known to 
enhance IL-10 synthesis (e.g., chlorpromazine, corticoste- 
roids) 4 should also be taken into account for the interpre- 
tation of the results reported. 
In our opinion, the different course of IL-10 observed 
by Sugita's group with a release showing its peak in the 
early postoperative period could be ascribed to the ad- 
ministration of corticosteroids in the priming solution. 
Indeed, by inhibiting the release of proinflammatory 
cytokines during CPB and by increasing IL-10 produc- 
tion, ~ corticosteroids might have limited both the magni- 
tude and uration of the inflammatory reaction induced 
by CPB and might have advanced the p ak concentration 
of IL-10 to an earlier time. Finally, as we showed in our 
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